Download PDF
Thromb Haemost 2001; 86(06): 1501-1511
DOI: 10.1055/s-0037-1616755
Review Article
Schattauer GmbH

Crotalin, a vWF and GP Ib Cleaving Metalloproteinase from Venom of Crotalus atrox

Wen-Bin Wu
1   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
,
Hui-Chin Peng
1   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
,
Tur-Fu Huang
1   Department of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan
› Author Affiliations
Further Information

Publication History

Received 08 June 2001

Accepted after resubmission 03 August 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

Binding of von Willebrand factor (vWF) to a variety of extracellular matrix (ECM) components and to platelet glycoprotein (GP) Ib-IX-V complex is important in mediating platelet adhesion and aggregation in the early stage of hemostasis. We previously purified a potent antithrombotic protein, named crotalin, functionally acting as a GP Ib antagonist (1). In this study, we further characterized crotalin as a P-I metalloproteinase with a molecular mass of 25 kDa as determined by gel filtration and two-dimensional SDS-PAGE. Crotalin is a vWF binding and cleaving metalloproteinase. In addition, crotalin cleaved platelet GP Ib as judged by flow cytometry and Western blotting. The multiple effects of crotalin on vWF and platelet GP Ib antagonized ristocetin-, but not collagen and thrombin-induced platelet aggregation, suggesting that its effect is specific. We also found that crotalin auto-proteolytically degraded to ~14 and ~10 kDa fragments in the presence of SDS. Interestingly, both degradation fragments, intact and reduced crotalin were able to bind vWF, suggesting the binding of crotalin to vWF is conformation-independent. In conclusion, the results presented further explain the potent antithrombotic effect of crotalin in vivo. In addition, the multiple effects of crotalin may be used as a tool to determine the binding motifs that are responsible for the vWF-ECMs or vWF-GP Ib interaction.

Keywords

Metalloprotease - autoproteolysis - ristocetin - vWF - GP Ib - platelet aggregation
 

  • References

  • 1 Chang MC, Lin HK, Peng HC, Huang TF. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox . Blood 1998; 91: 1582-9.
    PubMedGoogle Scholar
  • 2 Ware J. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Thromb Haemost 1998; 79: 466-78.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Andrews RK, Gorman JJ, Booth WJ, Corino GL, Castaldi PA, Berndt MC. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor Leu-480/Val-481-Gly-718 to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bissulfosuccinimidyl suberate. Biochemistry 1989; 28: 8326-36.
    CrossrefPubMedGoogle Scholar
  • 4 Berndt MC, Ward CM, Booth WJ, Castaldi PA, Mazurov AV, Andrews RK. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992; 31: 11144-51.
    CrossrefPubMedGoogle Scholar
  • 5 Hanada M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem 1986; 261: 12579-85.
    PubMedGoogle Scholar
  • 6 Vincente V, Houghten RA, Ruggeri ZM. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990; 265: 274-80.
    PubMedGoogle Scholar
  • 7 Don JF, Berndt MC, Schade A, Mclntire LV, Andrews RW, Lopez JA. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Blood 2001; 97: 162-8.
    CrossrefPubMedGoogle Scholar
  • 8 Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996; 87: 4223-34.
    PubMedGoogle Scholar
  • 9 Gralnick HR, Williams SB, Mckeown LP, Maisonneuve P, Jenneau C, Sultan Y, Rick ME. In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand’s disease. Proc Natl Acad Sci USA 1985; 82: 5968-72.
    CrossrefPubMedGoogle Scholar
  • 10 Zimmerman TS, Dent JA, Ruggeri ZM, Nannini LH. Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers Types IIC, IID and IIEd. J Clin Invest 1986; 77: 947-51.
    CrossrefPubMedGoogle Scholar
  • 11 Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azacar J, Seder RH, Hong SL, Deykin D. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
    CrossrefPubMedGoogle Scholar
  • 12 Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 1996; 87: 4235-44.
    PubMedGoogle Scholar
  • 13 Hite LA, Jia LG, Bjarnason JB, Fox JW. cDNA sequences for four snake venom metalloproteinases: structure, classification, and their relationship to mammalian reproductive proteins. Arch Biochem Biophys 1994; 308: 182-91.
    CrossrefPubMedGoogle Scholar
  • 14 Huang TF, Chang MC, Peng HC, Teng CM. A novel alpha-type fibrinogenase from Agkistrodon rhodostoma snake venom. Biochim Biophys Acta 1992; 1160: 262-8.
    CrossrefPubMedGoogle Scholar
  • 15 Huang TF, Chang MC, Teng CM. Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib. Biochim Biophys Acta 1993; 1158: 293-9.
    CrossrefPubMedGoogle Scholar
  • 16 Ward CM, Vinogradov DV, Andrews RK, Berndt MC. Characterization of mocarhagin, a cobra venom metalloproteinase from Naja mocambique mocambique, and related proteins from other Elapidae venoms. Toxicon 1996; 34: 1203-6.
    CrossrefPubMedGoogle Scholar
  • 17 Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Iba. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Iba as a binding site for von Wille-brand factor and a-thrombin. Biochemistry 1996; 35: 4929-38.
    CrossrefPubMedGoogle Scholar
  • 18 Hamako J, Matsui T, Nishida S, Nomura S, Fujimura Y, Ito M, Ozeki Y, Titani K. Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naha kaouthia cobra venom. Thromb Haemost 1998; 80: 499-505.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Ito M, Hamako J, Sakurai Y, Matsumoto M, Fujimura Y, Suzuki M, Hashimoto K, Titani K, Matsui T. Complete amino acid sequence of kaouthiagin, a novel cobra venom metalloproteinase with two disintegrin-like sequences. Biochemistry 2001; 40: 4503-11.
    CrossrefPubMedGoogle Scholar
  • 20 Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983; 61: 99-110.
    PubMedGoogle Scholar
  • 21 Michelson AD, Loscalzo J, Melnick B, Coller BS, Handin RI. Partial characterization of a binding site for von Willebrand factor on glycocalicin. Blood 1986; 67: 19-26.
    PubMedGoogle Scholar
  • 22 Montgomery RR, Kunicki TJ, Pidard D, Corcoran M. Diagnosis of Bernard-Soulier syndrome and Glanzmann’s thrombothennia with a monoclonal assay on whole blood. J Clin Invest 1983; 71: 385-9.
    CrossrefPubMedGoogle Scholar
  • 23 Newman J, Johnson AJ, Karpatkin MH, Puszkin S. Methods for the production of clinically effective intermediate and high-purity factor-VIII concentrates. Br J Haematol 1971; 21: 1-20.
    CrossrefPubMedGoogle Scholar
  • 24 Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204.
    CrossrefPubMedGoogle Scholar
  • 25 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-3.
    PubMedGoogle Scholar
  • 26 Baramova EN, Shannon JD, Bjarnason JB, Fox JW. Degradation of extra-cellular matrix proteins by hemorrhagic metalloproteinases. Arch Biochem Biophys 1989; 275: 63-71.
    CrossrefPubMedGoogle Scholar
  • 27 Bjarnason JB, Fox JW. Snake venom metalloendopeptidases: reprolysins. Methods Enzymol 1995; 248: 345-68.
    PubMedGoogle Scholar
  • 28 Fujimura S, Oshikawa K, Terada S, Kimoto E. Primary structure and autoproteolysis of brevilysin H6 from the venom of Gloydius halys brevicaudus . J Biochem 2000; 128: 167-73.
    CrossrefPubMedGoogle Scholar
  • 29 Wu WB, Chang SC, Laiu MY, Hunag TF. Purification, molecular cloning and mechanism of action of graminelysin I, a snake-venom derived metalloproteinase that induces apoptosis of human endothelial cells. Biochem J 2001; 357: 719-28.
    CrossrefPubMedGoogle Scholar
  • 30 Fox JW, Bjarnason JB. Atrolysins: Metalloproteinases from Crotalus atrox . Methods Enzymol 1995; 248: 368-87.
    PubMedGoogle Scholar
  • 31 Takeya H, Oda K, Miyata T, Omori-Satoh T, Iwanaga S. The complete amino acid sequence of the high molecular mass hemorrhagic protein HR1B isolated from the venom of Trimeresurus flavoviridis . J Biol Chem 1990; 265: 16068-73.
    PubMedGoogle Scholar
  • 32 Takeya H, Nishida S, Nishino N, Makinose Y, Omori-Satoh T, Nikai T, Sugihara H, Iwanaga S. Primary structures of platelet aggregation inhibitors disintegrins autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. J Biochem 1993; 113: 473-83.
    CrossrefPubMedGoogle Scholar
  • 33 Hite LA, Shannon JD, Bjarnason JB, Fox JW. Sequence of a cDNA clone encoding the zinc metalloproteinase hemorrhagic toxin e from Crotalus atrox: evidence for signal, zymogen, and disintegrin-like structure. Biochemistry 1992; 31: 6203-11.
    CrossrefPubMedGoogle Scholar
  • 34 Jandrot-Perrus M, Clemetson KJ, Guillin MC, Bouton MC. Binding of heparin to platelet membrane glycoprotein Ib: functional effects. Thromb Haemost 1998; 81: 316-7.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Bjarnason JB, Hamilton D, Fox JW. Studies on the mechanism of hemorrhage production by five proteolytic hemorrhagic toxins from Crotalus atrox venom. Biol Chem Hoppe Seyler 1988; 369 Suppl 121-9.
    PubMedGoogle Scholar
  • 36 De Luca M, Dunlop LC, Andrews RK, Flannery Jr JV, Ettling R, Cumming DA, Veldman GM, Berndt MC. A novel cobra venom metalloproteinase, mocarhagin, cleaves a 10-amino acid peptide from the mature N terminus of P-selectin glycoprotein ligand receptor, PSGL-1, and abolishes P-selectin binding. J Biol Chem 1995; 270: 26734-7.
    CrossrefPubMedGoogle Scholar
  • 37 Peng M, Lu W, Beviglia L, Niewiarowski S, Kirby EP. Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib. Blood 1993; 81: 2321-8.
    PubMedGoogle Scholar
  • 38 Fujimura Y, Miura IS, Yoshida E, Shima H, Nishida S, Suzuki M, Titani K, Taniuchi Y, Kawasaki T. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Thromb Haemost 1995; 74: 743-50.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Navdaev A, Dormann D, Clemetson JM, Clemetson KJ. Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction. Blood 2001; 97: 2333-41.
    CrossrefPubMedGoogle Scholar